Literature DB >> 22191447

Current developments and future perspectives for TB diagnostics.

Juan Carlos Palomino1.   

Abstract

TB persists as a global epidemic with high morbidity and mortality, especially in low-income countries. It is the only infectious disease ever declared as a global emergency by the WHO. The HIV pandemic and the emergence of drug resistance represent two additional obstacles to better control of the disease. Important progress has been made in the last decade in TB diagnostics. Major needs still exist, such as the availability of a real point-of-care test, a better diagnosis of TB in immune-compromised populations and in children, and the possibility to predict progression to disease in latently infected people. This review will summarize the current developments in TB diagnostics and the perspectives for future developments in the field.

Entities:  

Mesh:

Year:  2012        PMID: 22191447     DOI: 10.2217/fmb.11.133

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  4 in total

1.  Comparison of the interferon-gamma release assay with the traditional methods for detecting Mycobacterium tuberculosis infection in children.

Authors:  Jianwei Zhou; Cui Kong; Yanxi Shi; Zhaocai Zhang; Zhaohong Yuan
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 2.  Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.

Authors:  Yan Feng; Sijun Liu; Qungang Wang; Liang Wang; Shaowen Tang; Jianming Wang; Wei Lu
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

3.  Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis.

Authors:  Nguyen Thi Quynh Nhu; Dang Thi Minh Ha; Nguyen Duc Anh; Do Dang Anh Thu; Tran Ngoc Duong; Nguyen Dang Quang; Nguyen Thi Ngoc Lan; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Do Chau Giang; Nguyen Huy Dung; Marcel Wolbers; Jeremy Farrar; Maxine Caws
Journal:  BMC Infect Dis       Date:  2013-01-23       Impact factor: 3.090

Review 4.  Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Authors:  Surendra K Sharma; Alladi Mohan
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.